SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
RG6501 (OpRegen®) Phase 1/2a Clinical Study 36 Month Results to Be Featured at Clinical Trials at the Summit 2025
May 12, 2025
 · 
7 min read
Press Releases
Aera Therapeutics Appoints Paul Conrad, Ph.D., MBA, as Chief Business and Financial Officer
May 12, 2025
 · 
2 min read
Press Releases
UroGen Pharma Reports First Quarter 2025 Financial Results and Provides a Business Update
May 12, 2025
 · 
19 min read
Press Releases
HistoSonics Secures First Major Insurance Coverage for Non-Invasive Histotripsy Treatment for Liver Tumors With Blue Cross Blue Shield of Michigan
May 12, 2025
 · 
4 min read
Press Releases
Armatus Bio Selected as Finalist for XPRIZE Healthspan FSHD Bonus Prize
May 12, 2025
 · 
2 min read
Press Releases
Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si’s Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
May 12, 2025
 · 
5 min read
Press Releases
Epicrispr Biotechnologies Named Finalist in XPRIZE Healthspan Competition FSHD Bonus Prize
May 12, 2025
 · 
2 min read
Press Releases
IPA’s LENSai™ Platform Delivers X-Ray–Level Epitope Mapping Insights in Hours, Matching Gold-Standard Methods with Greater Speed
May 12, 2025
 · 
5 min read
Press Releases
Veradigm Advances GLP-1 Real-World Evidence Generation with AI-Driven EHR Data Curation
May 12, 2025
 · 
3 min read
Press Releases
Capsida Receives FDA IND Clearance for Its First-in-Class, IV-administered Gene Therapy for STXBP1 Developmental and Epileptic Encephalopathy
May 12, 2025
 · 
3 min read
Press Releases
Managing Director Peter Soelkner Leaves Role at Vetter
- Board thanks him for his outstanding commitment and successful collaboration - Managing Director Carsten Press to take over his responsibilities
May 12, 2025
 · 
1 min read
Press Releases
Amylyx Pharmaceuticals Announces Positive Long-Term Results from Phase 2 HELIOS Clinical Trial of AMX0035 in People with Wolfram Syndrome
May 12, 2025
 · 
9 min read
Press Releases
Ensoma Announces FDA Clearance of IND Application for First In Vivo HSC-Directed Gene Insertion Therapy
May 12, 2025
 · 
4 min read
Press Releases
Alnylam to Share Progress Across its Transthyretin Amyloidosis Franchise Including Additional Analyses of the HELIOS-B Phase 3 Study Results at Heart Failure 2025 Congress
May 12, 2025
 · 
5 min read
Press Releases
Newron Announces Approval for Pivotal Phase III ENIGMA-TRS Program With Evenamide as Add-on Therapy in Patients With Treatment-resistant Schizophrenia (TRS)
May 12, 2025
 · 
11 min read
Press Releases
Circle Pharma to Present Trials in Progress Poster on CID-078, a First-in-Class Cyclin A/B Inhibitor, at the ASCO 2025 Annual Meeting
May 12, 2025
 · 
3 min read
Press Releases
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
May 12, 2025
 · 
7 min read
Press Releases
Helius Medical Technologies, Inc. Announces Reimbursement by Major Healthcare Provider for its Portable Neuromodulation Stimulator (PoNS®) Device
May 12, 2025
 · 
5 min read
Press Releases
AAVantgarde presents positive clinical data from its AAVB-081 program for Usher 1B and preclinical data from its AAVB-039 program for Stargardt at the ARVO 2025 annual meeting
May 12, 2025
 · 
2 min read
Press Releases
Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
 · 
13 min read
Press Releases
BioXcel Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
May 12, 2025
 · 
15 min read
Press Releases
Lexeo Therapeutics Reports First Quarter 2025 Financial Results and Operational Highlights
May 12, 2025
 · 
8 min read
Press Releases
Harvard Bioscience Announces First Quarter 2025 Financial Results
May 12, 2025
 · 
10 min read
Press Releases
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
May 12, 2025
 · 
10 min read
Press Releases
Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee (DSMC)
May 12, 2025
 · 
3 min read
Press Releases
Allarity Therapeutics Announces Participation in Pharma Partnering Summit US
May 12, 2025
 · 
4 min read
Press Releases
Secarna Pharmaceuticals and Curie.Bio Portfolio Company Enter into Research and Option Agreement
May 12, 2025
 · 
3 min read
Press Releases
Moolec Science Announces Effectiveness of Reverse Stock Split
May 12, 2025
 · 
3 min read
Press Releases
Alterity Therapeutics Prominently Featured at the International MSA Congress
May 12, 2025
 · 
13 min read
Press Releases
CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China
May 12, 2025
 · 
7 min read
Press Releases
Moleculin Receives European Medicines Agency Approval to Expand Phase 3 MIRACLE Clinical Trial
May 12, 2025
 · 
8 min read
Press Releases
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025
May 12, 2025
 · 
2 min read
Press Releases
ElevateBio Appoints Ger Brophy, Ph.D., as Interim Chief Executive Officer and Member of the Board of Directors
May 12, 2025
 · 
3 min read
Press Releases
Oragenics, Inc. to Host Management Update Webinar on May 20, 2025 to Discuss Concussion Treatment Landscape, ONP-002 Clinical Program, and Strategic Vision
May 12, 2025
 · 
3 min read
Load More